Filter
259
Text search:
molecular
markers
Featured
Recommendations
36
New Publications
54
Language
Document type
No document type
124
Guidelines
59
Studies & Reports
41
Manuals
16
Fact sheets
9
Strategic & Response Plan
4
Training Material
3
Situation Updates
2
Resource Platforms
1
Countries / Regions
India
32
Global
11
Africa
8
Kenya
7
Latin America and the Carribbean
7
South Africa
4
Tanzania
3
Brazil
3
Sierra Leone
2
Philippines
2
Pakistan
2
West and Central Africa
2
Venezuela
2
Liberia
1
Nigeria
1
Congo, Democratic Republic of
1
USA
1
Ethiopia
1
Cameroon
1
Uganda
1
Zimbabwe
1
Nepal
1
Afghanistan
1
Zambia
1
Syria
1
Malawi
1
Benin
1
Peru
1
South–East Asia Region
1
Western Pacific Region
1
Western and Central Europe
1
Asia
1
Eastern Europe
1
Georgia
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
64
Clinical Guidelines
55
Public Health
23
Pharmacy & Technologies
14
Key Resources
5
Women & Child Health
4
Capacity Building
2
Toolboxes
COVID-19
34
TB
28
HIV
17
Mental Health
17
NTDs
16
AMR
14
NCDs
14
Rapid Response
12
Ebola
5
Refugee
4
Pharmacy
4
Planetary Health
3
Disability
2
Cholera
2
Specific Hazards
2
Polio
1
Conflict
1
Natural Hazards
1
Zika
1
Global Health Education
1
Caregiver
1
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug
...
Chapter 2 in "Latest Findings in Intellectual and Developmental Disabilities Research" Edited by Üner Tan, ISBN 978-953-307-865-6, 404 pages, Publisher: InTech, Chapters published February 15, 2012 under CC BY 3.0 license | Intellectual and Developmental Disabilities presents reports on a wide rang
...
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent
...
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; challenges in health systems that influence TB care;
...
J Infect Dis. (2012) 206 (suppl. 1): S61-S67
Influenza data gaps in sub-Saharan Africa include incidence, case fatality, seasonal patterns, and associations with prevalent disorders. The authors found that the burden of influenza was small during 2007–2010 in this paediatric hospital in Kenya. In
...
FIND and Standard Diagnostics (SD) have developed a lateral flow rapid diagnostic test (RDT) to screen for
T.b. gambiense HAT that is cheap and easy to use. The tests are packed individually and are stable at 40°C for
up to 25 months; they are performed on fresh blood obtained from a finger prick
...
Training module on malaria control
Asbestos, the most frequent cause of occupational cancer, continues to be consumed ona massive scale, with millions of people exposed on a daily basis. This review explains why we havefailed in curtailing the silent epidemic of asbestos-related disease and why the numbers of asbestosvictims are like
...
3rd Edition – July 2017
www.msfaccess.org
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
